Identification of these interactions between KRAS and H3K9la provided a better understanding of the mechanisms by which KRAS affects CRC progression, and might provide novel insights on potential therapeutic strategies for treating KRAS mutant tumors. Here, KRAS is linked to colorectal carcinoma.